WallStreetZenWallStreetZen

NASDAQ: SEER
Seer Inc Stock

Overview
ForecastEarningsDividendOwnership
$3.78+0.14 (+3.85%)
Updated Mar 23, 2023
SEER Price
$3.78
Fair Value Price
$4.63
Market Cap
$240.95M
52 Week Low
$3.59
52 Week High
$16.53
P/E
-2.54x
P/B
0.54x
P/S
23.37x
PEG
N/A
Dividend Yield
N/A
Revenue
$15.49M
Earnings
-$92.97M
Gross Margin
45.8%
Operating Margin
-600.05%
Profit Margin
-600.1%
Debt to Equity
0.09
Operating Cash Flow
-$61M
Beta
2.44
Next Earnings
May 2, 2023
Ex-Dividend
N/A
Next Dividend
N/A

SEER Overview

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Zen Score

–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SEER scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SEER ($3.78) is undervalued by 18.4% relative to our estimate of its Fair Value price of $4.63 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SEER ($3.78) is not significantly undervalued (18.4%) relative to our estimate of its Fair Value price of $4.63 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SEER is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SEER due diligence checks available for Premium users.

Be the first to know about important SEER news, forecast changes, insider trades & much more!

SEER News

Valuation

SEER fair value

Fair Value of SEER stock based on Discounted Cash Flow (DCF)
Price
$3.78
Fair Value
$4.63
Undervalued by
18.40%
SEER ($3.78) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SEER ($3.78) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SEER is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SEER price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.54x
Industry
17.21x
Market
21.14x

SEER price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.54x
Industry
4.84x
SEER is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SEER's financial health

Profit margin

Revenue
$4.6M
Net Income
-$22.5M
Profit Margin
-489.1%
SEER's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SEER's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$487.9M
Liabilities
$40.9M
Debt to equity
0.09
SEER's short-term assets ($434.98M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SEER's short-term assets ($434.98M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SEER's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$14.3M
Investing
-$2.7M
Financing
$2.1M
SEER's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SEER vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
SEER$240.95M+3.99%-2.54x0.54x
LCTX$238.20M+2.19%-9.33x3.25x
KZR$237.19M-5.10%-3.32x0.88x
ICVX$245.39M-1.28%-6.47x1.09x
HRTX$245.50M+4.82%-0.99x10.94x
View Top Biotech Stocks

Seer Stock FAQ

What is Seer's quote symbol?

NASDAQ: SEER) Seer trades on the NASDAQ under the ticker symbol SEER. Seer stock quotes can also be displayed as NASDAQ: SEER.

If you're new to stock investing, here's how to buy Seer stock.

What is the 52 week high and low for Seer (NASDAQ: SEER)?

(NASDAQ: SEER) Seer's 52-week high was $16.53, and its 52-week low was $3.59. It is currently -77.13% from its 52-week high and 5.29% from its 52-week low.

How much is Seer stock worth today?

(NASDAQ: SEER) Seer currently has 63,744,580 outstanding shares. With Seer stock trading at $3.78 per share, the total value of Seer stock (market capitalization) is $240.95M.

Seer stock was originally listed at a price of $56.46 in Dec 4, 2020. If you had invested in Seer stock at $56.46, your return over the last 2 years would have been -93.3%, for an annualized return of -74.13% (not including any dividends or dividend reinvestments).

How much is Seer's stock price per share?

(NASDAQ: SEER) Seer stock price per share is $3.78 today (as of Mar 23, 2023).

What is Seer's Market Cap?

(NASDAQ: SEER) Seer's market cap is $240.95M, as of Mar 24, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Seer's market cap is calculated by multiplying SEER's current stock price of $3.78 by SEER's total outstanding shares of 63,744,580.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.